Literature DB >> 33847772

Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists.

Malak Itani1, Neeraj Lalwani2, Dhakshinamoorthy Ganeshan3, Maria Zulfiqar1, Cary Siegel1.   

Abstract

More than one-fifth of ovarian cancers are hereditary, with most of them caused by BRCA genes. Malignant ovarian neoplasms are primarily epithelial tumors, a heterogeneous group of tumors with variable genetic backgrounds that translate into different biologic behaviors and morphologic features. Radiologists play an increasingly important role in the diagnosis and management of oncology patients. Familiarity with hereditary ovarian cancers will have a positive impact on patient management and radiologists' involvement in the multidisciplinary approach needed for this delicate patient population. In this paper, we review the basic histologic and genetic backgrounds of ovarian tumors with an emphasis on hereditary ovarian cancers, as well as the effects that these factors have on patient workup, primarily with regard to imaging studies.

Entities:  

Keywords:  BRCA mutation; Gorlin syndrome; Hereditary ovarian cancer; Lynch syndrome; Peutz-Jeghers syndrome

Year:  2021        PMID: 33847772     DOI: 10.1007/s00261-020-02911-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  51 in total

Review 1.  Forth nightly review: hereditary ovarian carcinoma.

Authors:  L Kasprzak; W D Foulkes; A N Shelling
Journal:  BMJ       Date:  1999-03-20

Review 2.  Malignant ovarian germ-cell tumours.

Authors:  Jeffrey J H Low; Arunachalam Ilancheran; Joseph S Ng
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-02-01       Impact factor: 5.237

3.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

4.  Brenner tumor of the ovary - ultrasound features and clinical management of a rare ovarian tumor mimicking ovarian cancer.

Authors:  Vit Weinberger; Luboš Minář; Michal Felsinger; Petra Ovesná; Markéta Bednaříková; Marta Číhalová; Eva Jandáková; Jitka Hausnerová; Barbora Chaloupková; Michal Zikán
Journal:  Ginekol Pol       Date:  2018       Impact factor: 1.232

5.  Epithelial ovarian cancer: An overview.

Authors:  Arpita Desai; Jingyao Xu; Kartik Aysola; Yunlong Qin; Chika Okoli; Ravipati Hariprasad; Ugorji Chinemerem; Candace Gates; Avinash Reddy; Omar Danner; Geary Franklin; Anachebe Ngozi; Guilherme Cantuaria; Karan Singh; William Grizzle; Charles Landen; Edward E Partridge; Valerie Montgomery Rice; E Shyam P Reddy; Veena N Rao
Journal:  World J Transl Med       Date:  2014-04-12

6.  CT and MRI findings of sex cord-stromal tumor of the ovary.

Authors:  Seung Eun Jung; Sung Eun Rha; Jae Mun Lee; Soo Youn Park; Soon Nam Oh; Kyoung Sik Cho; Eun Ju Lee; Jae Young Byun; Seong Tai Hahn
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

Review 7.  Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.

Authors:  R J Kurman
Journal:  Ann Oncol       Date:  2013-12       Impact factor: 32.976

8.  Diagnosis and Management of Ovarian Cancer.

Authors:  Chyke A Doubeni; Anna R Doubeni; Allison E Myers
Journal:  Am Fam Physician       Date:  2016-06-01       Impact factor: 3.292

Review 9.  Hereditary ovarian cancer: not only BRCA 1 and 2 genes.

Authors:  Angela Toss; Chiara Tomasello; Elisabetta Razzaboni; Giannina Contu; Giovanni Grandi; Angelo Cagnacci; Russell J Schilder; Laura Cortesi
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

Review 10.  Recent concepts of ovarian carcinogenesis: type I and type II.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Ikuo Konishi
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

View more
  1 in total

1.  Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway.

Authors:  Yiming Jia; Jingru Li; Jinfeng Wang; Tianjiao Luo; Xiaoqian Jing; Hongmin Zhao
Journal:  Anal Cell Pathol (Amst)       Date:  2022-05-13       Impact factor: 4.133

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.